Breaking News Instant updates and real-time market news.

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58

Axovant Sciences trading halted, news pending

AXON Axovant Sciences
$24.25

-0.74 (-2.96%)

07/10/17
JEFF
07/10/17
INITIATION
Target $40
JEFF
Buy
Axovant Sciences initiated with a Buy at Jefferies
Jefferies analyst Michael Yee initiated Axovant Sciences with a Buy and a $40 price target.
07/12/17
OPCO
07/12/17
NO CHANGE
OPCO
Outperform
Axovant Sciences upcoming results may drive valuation upside, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Axovant Sciences faces two substantial binary events including the Phase 3 MINDSET study results at the end of September and the Phase 2 HEADWAY study results in Q4. The combination of these two events could drive up to 100% valuation upside, he contends. Further, the analyst believes the company is positioned to deliver the first new symptomatic Alzheimer's Disease drug approved by the FDA in over a decade. Olson reiterates an Outperform rating on the shares.
09/08/17
EVER
09/08/17
NO CHANGE
Target $30
EVER
Outperform
Axovant Sciences assumed with an Outperform at Evercore ISI
Evercore ISI analyst Josh Schimmer assumed coverage on Axovant Sciences with an Outperform and a $30 price target.
09/14/17
JEFF
09/14/17
NO CHANGE
Target $40
JEFF
Buy
Axovant looks 'very intriguing' at $20 per share, says Jefferies
Jefferies analyst Michael Yee believes the recent selloff in shares of Axovant Sciences presents a "unique" buying opportunity. At around $20 per share, the stock looks "very intriguing," Yee tells investors in a research note. The analyst sees "significant" potential upside, to $40-$100 per share, if the Phase III Alzheimer's data this month is positive. Yee's downside case is $3-$10 per share on negative data. Investors "should and will" buy the large selloff on negative data because CEO David Hung is likely to pivot the company, bring in more assets, and create value "from there pretty quickly," the analyst contends. Yee has a Buy rating on Axovant with a $40 price target. He thinks the Phase III Alzheimer's data has a 50%-60% chance of being positive.

TODAY'S FREE FLY STORIES

IBKC

Iberiabank

$83.10

-1.2 (-1.42%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Hot Stocks
Federal Reserve approves Iberiabank purchase of Gibraltar Private Bank »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZN

Zion Oil & Gas

$4.47

0.43 (10.64%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Periodicals
Zion Oil & Gas shares deserve 'to crater,' TheStreetSweeper says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

, LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

12:07
02/21/18
02/21
12:07
02/21/18
12:07
Hot Stocks
Lionsgate slides as analyst cuts rating on competitive, cost concerns »

Bernstein analyst Todd…

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

DIS

Disney

$106.29

0.31 (0.29%)

FOX

21st Century Fox

$36.61

-0.43 (-1.16%)

FOXA

21st Century Fox

$37.13

-0.33 (-0.88%)

CMCSA

Comcast

$39.47

-0.32 (-0.80%)

CMCSK

Comcast

T

AT&T

$36.82

0.047 (0.13%)

TWX

Time Warner

$95.48

0.405 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 20

    Mar

  • 23

    Apr

ATVI

Activision Blizzard

$70.84

0.65 (0.93%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Periodicals
Activision's Sledgehammer founders leave studio, Kotaku reports »

Michael Condrey and Glen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

UNP

Union Pacific

$133.54

3.31 (2.54%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Hot Stocks
Union Pacific backs Q1 and FY18 volume goal of slightly positive »

Comments were made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TXN

Texas Instruments

$105.29

0.82 (0.78%)

12:01
02/21/18
02/21
12:01
02/21/18
12:01
Conference/Events
Texas Instruments management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 30

    May

BHGE

Baker Hughes

$27.48

1.04 (3.93%)

12:00
02/21/18
02/21
12:00
02/21/18
12:00
Options
Baker Hughes calls active as shares rally »

Baker Hughes calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

12:00
02/21/18
02/21
12:00
02/21/18
12:00
General news
FOMC minutes preview: »

FOMC minutes preview: the…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:55
02/21/18
02/21
11:55
02/21/18
11:55
Hot Stocks
Campbell expects $170M in cost synergies from Snyder's-Lance deal by FY22 »

CFO Anthony DiSilvestro…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

HBAN

Huntington Bancshares

$15.90

0.07 (0.44%)

11:50
02/21/18
02/21
11:50
02/21/18
11:50
Options
Call buyers in Huntington Bancshares »

Call buyers in Huntington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

11:50
02/21/18
02/21
11:50
02/21/18
11:50
General news
Treasury $15 B 2-year FRN reopening was weak »

Treasury $15 B 2-year FRN…

C

Citi

$77.50

1.0399 (1.36%)

11:47
02/21/18
02/21
11:47
02/21/18
11:47
Periodicals
Citi creates new position to supervise EMEA commodities banking, FT says »

According to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

, XLF

Financial Select Sector

$29.21

0.32 (1.11%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Technical Analysis
Technical Take: S&P 500 hits session highs at midday »

At time of writing the…

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

XLF

Financial Select Sector

$29.21

0.32 (1.11%)

XLB

S&P Select Materials SPDR

$60.73

0.52 (0.86%)

XLK

Technology Select Sector SPDR

$67.79

0.55 (0.82%)

XLRE

Real Estate SPDR

$30.23

-0.145 (-0.48%)

XLP

Consumer Staples Sector SPDR

$54.16

-0.18 (-0.33%)

SPY

SPDR S&P 500 ETF Trust

$273.35

1.945 (0.72%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

SLCA

U.S. Silica

$26.56

-4.195 (-13.64%)

11:40
02/21/18
02/21
11:40
02/21/18
11:40
Options
Buy the dip call activity in Silica Holdings as shares tumble on earnings »

Buy the dip call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Hot Stocks
Campbell expects Snyder's-Lance deal to deliver 'significant' cost synergies »

Says Snyder's-Lance…

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

PCRX

Pacira

$31.25

1.1 (3.65%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Recommendations
Pacira analyst commentary  »

Pacira Q4 sales momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Apr

AIDIF

Air Canada

11:35
02/21/18
02/21
11:35
02/21/18
11:35
Conference/Events
Air Canada management to meet with RBC Capital »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Options
25K Alerian MLP Mar 9th 10.5 puts trade for 20c on ISE »

25K Alerian MLP Mar 9th…

CPB

Campbell Soup

$45.38

-0.7 (-1.52%)

11:30
02/21/18
02/21
11:30
02/21/18
11:30
Hot Stocks
Campbell Soup says goal is to become leading health and well-being food company »

President and CEO Denise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

PERY

Perry Ellis

$26.32

-0.52 (-1.94%)

11:28
02/21/18
02/21
11:28
02/21/18
11:28
Hot Stocks
Perry Ellis announces mens underwear, loungewear license in South Korea »

Earlier today, Perry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBL

Noble Energy

$29.48

0.36 (1.24%)

11:27
02/21/18
02/21
11:27
02/21/18
11:27
Recommendations
Noble Energy analyst commentary  »

Noble Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

DVN

Devon Energy

$32.86

-1.79 (-5.17%)

11:26
02/21/18
02/21
11:26
02/21/18
11:26
Hot Stocks
Devon Energy CEO confident that investor returns will increase in FY18 »

Devon Energy CEO David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.